了解粘膜生理学和配方设计的逻辑,以改善粘膜免疫力
Mila Biswas1, Md Nurunnabi2,3, Zehedina Khatun2
1Department of Electrical and Computer Engineering, University of Texas at El Paso, El Paso, Texas 79902, United States.
ACS applied bio materials
|May 24, 2024
概括
粘膜保护我们免受病原体的侵害. 像脂质体和粘膜颗粒这样的先进配方可以增强粘膜免疫力,以便更好地开发疫苗.
科学领域:
- 免疫学 免疫学 免疫学
- 生物材料科学 生物材料科学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 口腔和鼻腔中的粘膜是病原体的主要入口点.
- 粘膜屏障对于防御感染和维持平衡是必不可少的.
- 粘膜耐受性对于调节生理平衡至关重要.
研究的目的:
- 审查材料选择和输送系统在优化粘膜免疫力的作用.
- 突出粘膜配方在增强免疫反应方面的潜力.
主要方法:
- 关于粘膜免疫和配方的科学文献的审查.
- 基于脂质 (脂质体,病毒体) 和聚合物输送系统的分析.
- 评估表明免疫反应增强的研究.
主要成果:
- 基于脂质的配方 (脂质体,病毒体) 有效诱导局部和全身免疫力.
- 粘粘性聚合物颗粒提供了长时间的输送和增强的免疫反应.
- 材料选择和输送策略显著影响粘膜免疫力.
结论:
- 优化材料选择和输送方法是提高粘膜免疫力的关键.
- 使用先进配方的粘膜疫苗显示出改善免疫刺激的希望.
- 对粘膜输送系统的进一步研究可以导致更有效的疫苗.
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
446
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
446
Mucosal Barrier of the Stomach
625
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
625
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
380
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
380
Surface Membrane Barriers
1.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
408
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
408
Peptic Ulcer Disease II: Pathophysiology
390
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
390


